Indigix Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Indigix General Information

Description

Developer of medical monitoring platform intended for assessing defined immunological responses. The company's platform specializes in the research and development of synthetic molecules against immunological responses involved in a range of diseases in order for treatment of diarrheal diseases, inflammatory bowel disease, and wound healing, enabling the healthcare industry to treat diarrheal diseases in an efficient manner.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
  • 3 Kingsbrook Drive
  • Kingsbrook Drive
  • Solihull B91 3UU
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Indigix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 20-Sep-2016 00.000 Completed Out of Business
1. Seed Round 01-Dec-2010 00.000 00.000 00.000 Completed Startup
To view Indigix’s complete valuation and funding history, request access »

Indigix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref 2 0,000 00.000000 000.00 000.00 00 000.00 0.000
Pref 1 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Indigix’s complete cap table history, request access »